CEPI will provide funding of up to US $19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to an international multidisciplinary consortium
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
The research was supported by the BGU Coronavirus Challenge and the Israeli Ministry of Health.
The report has estimated 4.74 million deaths for India in 2020 and 2021,
CLNK is a biotechnology research and development company that utilizes umbilical cord blood as the raw material to develop innovative, allogeneic, off-the-shelf, cell based therapeutic products
Cysoni is a bionic device that paces the heart with real-time respiratory modulation
University of Pennsylvania scientists Katalin Karikó and Drew Weissman to be honoured at June 7 symposium in New York City for their research that enabled Covid-19 vaccines
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
This is the first major brand refresh of CanSinoBIO since its inception in 2009
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Subscribe To Our Newsletter & Stay Updated
